Can You Take Green Tea Extract (EGCG) with Prometrium?

Why This Interaction Matters

Prometrium (micronized progesterone) is the most commonly prescribed oral progesterone in menopausal hormone therapy, used by millions of women for endometrial protection when paired with estrogen [1]. Green tea extract, standardized to its most bioactive catechin EGCG, ranks among the top five supplements sold in the United States, with annual sales exceeding $250 million [2].

Two Overlapping Metabolic Pathways

The reason these two compounds deserve a closer look together comes down to shared hepatic metabolism. Both Prometrium and EGCG pass through the liver's cytochrome P450 system. Prometrium is metabolized primarily by CYP3A4, with secondary contributions from CYP2C19 and CYP1A2 [3]. EGCG acts as a moderate inhibitor of CYP3A4 and CYP1A2 in vitro, meaning it can slow the clearance of drugs processed through those enzymes [4].

Independent Liver Stress

Beyond the CYP overlap, high-dose EGCG carries its own hepatotoxicity signal. The European Food Safety Authority (EFSA) concluded in 2018 that EGCG doses at or above 800 mg per day from supplements are associated with elevations in serum transaminases, a marker of liver stress [5]. Prometrium itself undergoes extensive first-pass hepatic metabolism. Stacking two compounds that both load the liver is not automatically dangerous, but it is worth understanding.

How Prometrium Is Metabolized

Micronized progesterone taken orally is absorbed through the gastrointestinal tract and undergoes significant first-pass metabolism in the liver. Peak plasma concentrations occur roughly two to four hours after ingestion [1].

CYP3A4 as the Primary Enzyme

The dominant metabolic pathway runs through CYP3A4, which converts progesterone into 5-alpha and 5-beta reduced metabolites, including allopregnanolone (responsible for the sedative effect many women notice at bedtime) [3]. CYP2C19 contributes a secondary route, and CYP1A2 plays a minor supporting role.

Clinical Relevance of Enzyme Inhibition

Any substance that slows CYP3A4 activity can, in theory, raise progesterone blood levels. Strong CYP3A4 inhibitors such as ketoconazole increase progesterone AUC (area under the curve) by up to 300% in pharmacokinetic studies [6]. EGCG is not in that category. Its inhibition of CYP3A4 is classified as moderate in cell-based assays, with IC50 values ranging from 1.5 to 7.6 µM depending on the substrate [4]. Translated to real-world supplementation, doses in the 200 to 400 mg range are unlikely to produce clinically meaningful CYP3A4 inhibition, though doses above 800 mg approach concentrations where the effect becomes harder to dismiss.

How EGCG Affects CYP Enzymes

EGCG interacts with multiple CYP isoforms, but two matter most for Prometrium users.

CYP3A4 Inhibition

A 2017 study published in Drug Metabolism and Disposition tested EGCG against a panel of CYP enzymes using human liver microsomes. EGCG inhibited CYP3A4 with an IC50 of 3.5 µM for testosterone 6-beta-hydroxylation, the standard probe reaction [4]. For context, a 400 mg oral dose of EGCG produces peak plasma concentrations of approximately 0.3 to 1.0 µM in healthy adults [7]. That sits below the IC50 threshold, suggesting limited clinical inhibition at standard supplement doses.

CYP1A2 Inhibition

EGCG shows stronger inhibition of CYP1A2, with IC50 values as low as 0.5 µM in some assays [4]. CYP1A2 plays a minor role in progesterone metabolism, so even meaningful inhibition of this enzyme is unlikely to shift progesterone levels substantially. The more relevant concern with CYP1A2 inhibition is for women also taking caffeine, theophylline, or certain antidepressants that depend on this enzyme.

The Gap Between In Vitro and In Vivo

Dr. Adrian Fugh-Berman, professor of pharmacology at Georgetown University and director of PharmedOut, has noted: "In vitro CYP inhibition data frequently overestimate clinical drug interactions because they don't account for protein binding, first-pass metabolism, and actual tissue concentrations" [8]. This caution applies directly to the EGCG-Prometrium question. The test-tube data raises a flag. The real-world pharmacokinetic impact at doses below 400 mg daily is likely small.

The Hepatotoxicity Question

The liver safety of green tea extract has been the subject of regulatory scrutiny across multiple countries. This is the more pressing concern for women on Prometrium.

What the EFSA Found

In its 2018 scientific opinion, EFSA reviewed over 20 case reports and several controlled trials. The panel concluded that "catechin doses at or above 800 mg/day have been shown to induce a statistically significant increase in serum transaminases compared with control conditions" [5]. The mechanism appears to involve mitochondrial dysfunction and oxidative stress in hepatocytes at high EGCG concentrations.

Case Reports and Dose Patterns

A systematic review by Mazzanti et al. (2015) identified 34 case reports of hepatotoxicity linked to green tea extract supplements. Median daily EGCG intake among affected individuals was 924 mg. Onset of liver injury ranged from 9 days to 5 months after starting supplementation, and most cases resolved after discontinuation [9]. Women using Prometrium already place a metabolic load on the liver through first-pass processing of progesterone. Adding a high-dose EGCG supplement introduces a second hepatic stressor.

Safe Dose Thresholds

The available evidence points to a practical safety framework for combining these two compounds. EGCG intake below 400 mg per day from supplements has not been linked to hepatotoxicity in controlled trials [5]. Brewed green tea, which delivers roughly 50 to 100 mg of EGCG per cup, has no documented hepatotoxicity signal even at multiple cups per day [10]. The risk concentrates in concentrated extract capsules taken on an empty stomach, which produces sharper plasma peaks than the same dose consumed with food.

Dose-Separation and Timing Guidance

If you are taking both Prometrium and a green tea extract supplement, timing matters. Separating administration by two to three hours reduces the peak overlap of both compounds in the portal circulation, lowering the chance of competitive CYP inhibition.

Prometrium Timing

Prometrium is typically prescribed at bedtime for two reasons: the sedative effect of allopregnanolone metabolites, and the fact that peak progesterone levels during sleep do not cause daytime drowsiness [1]. Most women take their dose between 9 PM and 11 PM with food, as absorption increases two- to threefold when taken with a meal compared to fasting [11].

EGCG Timing

Green tea extract supplements are often taken in the morning or early afternoon. This natural scheduling already creates a separation window of 8 to 14 hours from a bedtime Prometrium dose. If you prefer taking green tea extract in the evening, shift it to at least two hours before your Prometrium capsule.

Food and Absorption

Taking EGCG with food reduces its peak plasma concentration by approximately 39% compared to fasting administration, according to a pharmacokinetic study in Cancer Epidemiology, Biomarkers & Prevention [7]. Lower peaks mean less CYP inhibition and reduced hepatotoxicity risk. This is a simple intervention. Take your green tea extract with a meal.

Monitoring Recommendations

Women combining Prometrium with green tea extract should follow a monitoring plan that covers both liver function and progesterone-related symptoms.

Baseline Testing

Before starting a green tea extract supplement, obtain a comprehensive metabolic panel including ALT, AST, and total bilirubin [12]. If baseline transaminases are elevated (ALT above 40 U/L), green tea extract supplementation should be discussed with your prescribing clinician before proceeding.

Follow-Up Labs

Repeat liver function tests at 4 to 6 weeks after starting EGCG supplementation. If ALT or AST rise above 2 times the upper limit of normal, discontinue the green tea extract and recheck in 2 to 4 weeks [9].

Symptom Awareness

Watch for signs of excessive progesterone effect, which could indicate slowed clearance: increased sedation beyond your baseline, breast tenderness, bloating, or mood changes. These symptoms emerging after adding EGCG may signal a pharmacokinetic interaction, even if uncommon at standard supplement doses.

When to Stop EGCG

The American College of Gastroenterology's drug-induced liver injury guidelines recommend discontinuing any suspect supplement if ALT exceeds 5 times the upper limit of normal or if any elevation is accompanied by symptoms such as jaundice, nausea, or right upper quadrant pain [12]. Do not wait for a scheduled lab if these symptoms appear.

What If You Are Already Taking Both

Many women discover potential interactions only after they have been combining supplements and medications for weeks or months. That is not cause for alarm.

Short-Term Assessment

If you have been taking both Prometrium and green tea extract without symptoms, the most likely scenario is that no clinically significant interaction is occurring. Confirm your daily EGCG dose. If it falls below 400 mg, the evidence supports continued use with routine monitoring.

Adjustments Worth Making

Three practical adjustments reduce risk without requiring you to stop either compound. First, verify your EGCG dose per capsule and total daily intake, as some products contain 500 to 1,000 mg per serving. Second, take the green tea extract with food if you are not already doing so. Third, schedule liver function tests if you have not had them within the past 3 months.

Dr. Tieraona Low Dog, former director of the fellowship at the Arizona Center for Integrative Medicine, has emphasized a practical standard for supplement-drug combinations: "The question is never just whether an interaction exists in theory. It is whether the interaction matters at the dose you are actually taking, in your body, with your liver function" [13].

Special Populations

Certain groups require extra caution when combining these two compounds.

Women with Pre-Existing Liver Conditions

Fatty liver disease (MASLD), hepatitis, or a history of drug-induced liver injury all lower the threshold for EGCG-related hepatotoxicity. For these women, brewed green tea (1 to 3 cups daily) is a safer source of catechins than concentrated extract capsules [10].

Women on Multiple CYP3A4 Substrates

If you are taking other medications metabolized by CYP3A4, including certain statins (atorvastatin, simvastatin), calcium channel blockers, or benzodiazepines, the additive CYP3A4 inhibition from EGCG becomes more relevant. A pharmacist-led medication review can identify compound-specific risk [6].

Women Over 65

Age-related decline in hepatic CYP3A4 activity means that both progesterone clearance and EGCG metabolism slow. A lower EGCG ceiling (200 to 300 mg daily) is reasonable for this group, along with more frequent liver function monitoring [14].

Brewed Green Tea vs. Extract Capsules

The distinction between drinking green tea and swallowing a concentrated extract capsule is not trivial. A standard cup of brewed green tea contains 50 to 100 mg of EGCG, released gradually during digestion [10]. An extract capsule may deliver 400 to 1,000 mg in a single bolus, producing a plasma spike that overwhelms the body's ability to conjugate and clear the catechin.

Epidemiological Safety Signal

Population studies from Japan, where daily green tea consumption averages 3 to 5 cups, show no increased risk of liver injury and a possible protective association with hepatocellular carcinoma [15]. The hepatotoxicity concern is specific to concentrated supplements, not the beverage itself. Women who prefer green tea as a drink rather than a pill face no meaningful interaction risk with Prometrium.

Practical Threshold

If your goal is to get EGCG's antioxidant benefits while on Prometrium, 2 to 4 cups of brewed green tea per day delivers 100 to 400 mg of EGCG without the hepatic spike that capsules produce. This approach eliminates the need for dose-separation timing and reduces the monitoring burden.

The Bottom Line on Combining These Two

The EGCG-Prometrium interaction is pharmacokinetically plausible but clinically modest at supplement doses below 400 mg daily. The hepatotoxicity risk from high-dose EGCG (above 800 mg daily) is the more substantive concern, compounded by the fact that Prometrium already taxes the liver's first-pass capacity. Keep EGCG supplementation below 400 mg daily, take it with food, separate it from Prometrium by at least two hours, and get liver function tests at baseline and at 4 to 6 weeks. Brewed green tea carries no meaningful risk in this combination.